Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2005 5
2006 6
2007 3
2008 2
2009 4
2010 2
2011 3
2012 4
2013 1
2014 4
2015 8
2016 3
2017 10
2018 9
2019 7
2020 2
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Results by year
Filters applied: . Clear all
Page 1
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nukiwa T; North-East Japan Study Group. Maemondo M, et al. Among authors: isobe h. N Engl J Med. 2010 Jun 24;362(25):2380-8. doi: 10.1056/NEJMoa0909530. N Engl J Med. 2010. PMID: 20573926 Free article. Clinical Trial.
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival.
Yokouchi H, Nishihara H, Harada T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Higuchi M, Honjo O, Minami Y, Watanabe N, Nishimura M, Suzuki H, Dosaka-Akita H, Isobe H. Yokouchi H, et al. Among authors: isobe h. Heliyon. 2020 Jul 13;6(7):e04439. doi: 10.1016/j.heliyon.2020.e04439. eCollection 2020 Jul. Heliyon. 2020. PMID: 32685741 Free PMC article.
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).
Fukumoto SI, Oizumi S, Harada M, Sukoh N, Nakano K, Fuke S, Sakakibara-Konishi J, Takamura K, Ito K, Fujita Y, Nishigaki Y, Harada T, Akie K, Kinoshita I, Amano T, Isobe H, Dosaka-Akita H, Nishimura M; Hokkaido Lung Cancer Clinical Study Group. Fukumoto SI, et al. Among authors: isobe h. Cancer Chemother Pharmacol. 2020 Jul;86(1):117-127. doi: 10.1007/s00280-020-04104-1. Epub 2020 Jun 20. Cancer Chemother Pharmacol. 2020. PMID: 32564128 Clinical Trial.
An oxyl/oxo mechanism for oxygen-oxygen coupling in PSII revealed by an x-ray free-electron laser.
Suga M, Akita F, Yamashita K, Nakajima Y, Ueno G, Li H, Yamane T, Hirata K, Umena Y, Yonekura S, Yu LJ, Murakami H, Nomura T, Kimura T, Kubo M, Baba S, Kumasaka T, Tono K, Yabashi M, Isobe H, Yamaguchi K, Yamamoto M, Ago H, Shen JR. Suga M, et al. Among authors: isobe h. Science. 2019 Oct 18;366(6463):334-338. doi: 10.1126/science.aax6998. Epub 2019 Oct 17. Science. 2019. PMID: 31624207 Free article.
Aqueous nanosilica dispersants for carbon nanotube.
Matsuda T, Minami D, Khoerunnisa F, Sunaga M, Nakamura M, Utsumi S, Itoh T, Fujimori T, Hayashi T, Hattori Y, Endo M, Isobe H, Onodera H, Kaneko K. Matsuda T, et al. Among authors: isobe h. Langmuir. 2015 Mar 17;31(10):3194-202. doi: 10.1021/la504599b. Epub 2015 Mar 3. Langmuir. 2015. PMID: 25706991
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
Furuta M, Sakakibara-Konishi J, Kikuchi H, Yokouchi H, Nishihara H, Minemura H, Harada M, Yamazaki S, Akie K, Fujita Y, Takamura K, Kojima T, Harada T, Minami Y, Watanabe N, Oizumi S, Suzuki H, Nishimura M, Dosaka-Akita H, Isobe H; Hokkaido Lung Cancer Clinical Study Group. Furuta M, et al. Among authors: isobe h. Oncologist. 2019 Nov;24(11):e1172-e1179. doi: 10.1634/theoncologist.2018-0676. Epub 2019 May 8. Oncologist. 2019. PMID: 31068386 Free PMC article.
Synthesis of Pd-Fe System Alloy Nanoparticles by Pulsed Plasma in Liquid.
Tamura S, Mashimo T, Yamamoto K, Kelgenbaeva Z, Ma W, Kang X, Koinuma M, Isobe H, Yoshiasa A. Tamura S, et al. Among authors: isobe h. Nanomaterials (Basel). 2018 Dec 18;8(12):1068. doi: 10.3390/nano8121068. Nanomaterials (Basel). 2018. PMID: 30567370 Free PMC article.
Expression of Notch1 and Numb in small cell lung cancer.
Kikuchi H, Sakakibara-Konishi J, Furuta M, Yokouchi H, Nishihara H, Yamazaki S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Harada T, Higuchi M, Honjo O, Minami Y, Watanabe N, Oizumi S, Suzuki H, Ishida T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M. Kikuchi H, et al. Among authors: isobe h. Oncotarget. 2017 Feb 7;8(6):10348-10358. doi: 10.18632/oncotarget.14411. Oncotarget. 2017. PMID: 28060745 Free PMC article.
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.
Saka H, Nishio M, Hida T, Nakagawa K, Sakai H, Nogami N, Atagi S, Takahashi T, Horinouchi H, Takenoyama M, Katakami N, Tanaka H, Takeda K, Satouchi M, Isobe H, Maemondo M, Goto K, Hirashima T, Minato K, Yada N, Tamura T. Saka H, et al. Among authors: isobe h. Jpn J Clin Oncol. 2021 Jan 1;51(1):106-113. doi: 10.1093/jjco/hyaa157. Jpn J Clin Oncol. 2021. PMID: 33020837 Free PMC article.
Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).
Miyanaga A, Kubota K, Hosomi Y, Okuma Y, Minato K, Fujimoto S, Okamoto H, Satouchi M, Isobe H, Aono H, Takiguchi Y, Gemma A; Tokyo Cooperative Oncology Group. Miyanaga A, et al. Among authors: isobe h. Jpn J Clin Oncol. 2019 Aug 1;49(8):749-754. doi: 10.1093/jjco/hyz064. Jpn J Clin Oncol. 2019. PMID: 31070750 Clinical Trial.
78 results